Literature DB >> 11261796

Differential expression of Toll-like receptor 2 in human cells.

T H Flo1, O Halaas, S Torp, L Ryan, E Lien, B Dybdahl, A Sundan, T Espevik.   

Abstract

Human Toll-like receptor 2 (TLR2) is a receptor for a variety of microbial products and mediates activation signals in cells of the innate immune system. We have investigated expression and regulation of the TLR2 protein in human blood cells and tissues by using two anti-TLR2 mAbs. Only myelomonocytic cell lines expressed surface TLR2. In tonsils, lymph nodes, and appendices, activated B-cells in germinal centers expressed TLR2. In human blood, CD14+ monocytes expressed the highest level of TLR2 followed by CD15+ granulocytes, and CD19+ B-cells, CD3+ T-cells, and CD56+ NK cells did not express TLR2. The level of TLR2 on monocytes was after 20 h up-regulated by LPS, GM-CSF, IL-1, and IL-10 and down-regulated by IL-4, IFN-gamma, and TNF. On purified granulocytes, LPS, GM-CSF, and TNF down-regulated, and IL-10 modestly increased TLR2 expression after 2 h. These data suggest that TLR2 protein expression in innate immune cells is differentially regulated by inflammatory mediators.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11261796

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  76 in total

Review 1.  Naive and memory B cells in T-cell-dependent and T-independent responses.

Authors:  R H Zubler
Journal:  Springer Semin Immunopathol       Date:  2001-12

2.  Regulation of Toll-like receptor (TLR)2 and TLR4 on CD14dimCD16+ monocytes in response to sepsis-related antigens.

Authors:  N A Skinner; C M MacIsaac; J A Hamilton; K Visvanathan
Journal:  Clin Exp Immunol       Date:  2005-08       Impact factor: 4.330

3.  Lipoprotein-dependent and -independent immune responses to spirochetal infection.

Authors:  Juan C Salazar; Constance D Pope; Meagan W Moore; Jonathan Pope; Thomas G Kiely; Justin D Radolf
Journal:  Clin Diagn Lab Immunol       Date:  2005-08

4.  Differential expression of Toll-like receptor (TLR)-2 and TLR-4 on monocytes in human sepsis.

Authors:  L Armstrong; A R L Medford; K J Hunter; K M Uppington; A B Millar
Journal:  Clin Exp Immunol       Date:  2004-05       Impact factor: 4.330

5.  Cellular trafficking of lipoteichoic acid and Toll-like receptor 2 in relation to signaling: role of CD14 and CD36.

Authors:  Nadra J Nilsen; Susanne Deininger; Unni Nonstad; Frode Skjeldal; Harald Husebye; Dmitrii Rodionov; Sonja von Aulock; Thomas Hartung; Egil Lien; Oddmund Bakke; Terje Espevik
Journal:  J Leukoc Biol       Date:  2008-05-05       Impact factor: 4.962

6.  Suppression of Th1 Priming by TLR2 Agonists during Cutaneous Immunization Is Mediated by Recruited CCR2+ Monocytes.

Authors:  Christopher T Johndrow; Michael F Goldberg; Alison J Johnson; Tony W Ng; Shajo Kunnath-Velayudhan; Gregoire Lauvau; Daniel H Kaplan; Graeme H Gossel; Ulrich D Kadolsky; Andrew J Yates; John Chan; William R Jacobs; Steven A Porcelli
Journal:  J Immunol       Date:  2018-11-19       Impact factor: 5.422

7.  No evidence of altered alveolar macrophage polarization, but reduced expression of TLR2, in bronchoalveolar lavage cells in sarcoidosis.

Authors:  Maria Wikén; Farah Idali; Muntasir Abo Al Hayja; Johan Grunewald; Anders Eklund; Jan Wahlström
Journal:  Respir Res       Date:  2010-09-02

8.  TLR4 signaling induces TLR2 expression in endothelial cells via neutrophil NADPH oxidase.

Authors:  Jie Fan; Randall S Frey; Asrar B Malik
Journal:  J Clin Invest       Date:  2003-10       Impact factor: 14.808

Review 9.  Pattern recognition receptor-dependent mechanisms of acute lung injury.

Authors:  Meng Xiang; Jie Fan
Journal:  Mol Med       Date:  2009-11-02       Impact factor: 6.354

10.  Differential expression of Toll-like receptors on human alveolar macrophages and autologous peripheral monocytes.

Authors:  Esmeralda Juarez; Carlos Nuñez; Eduardo Sada; Jerrold J Ellner; Stephan K Schwander; Martha Torres
Journal:  Respir Res       Date:  2010-01-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.